Investigating apolipoproteins of human high-density lipoprotein by cyclodextrin-micellar electrokinetic chromatography

被引:2
作者
Hsu, Yun-Hsun [1 ]
Toh, Jia-Jia [1 ]
Chang, Chiz-Tzung [2 ]
Liu, Mine-Yine [1 ]
机构
[1] Natl Changhua Univ Educ, Dept Chem, Changhua 50058, Taiwan
[2] China Med Univ, Coll Med, Taichung, Taiwan
关键词
Apolipoproteins; HDL; CD-MEKC; Bile salts; Carboxymethyl-beta-cyclodextrin; REVERSE CHOLESTEROL TRANSPORT; AMINO-ACID-SEQUENCE; A-II; CAPILLARY-ELECTROPHORESIS; CARDIOVASCULAR-DISEASE; HDL COMPOSITION; HUMAN PLASMA; APOA-I; C-III; INFLAMMATION;
D O I
10.1016/j.chroma.2019.01.073
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A cyclodextrin-micellar electrokinetic chromatography (CD-MEKC) method has been developed to determine the apolipoproteins (apos) of human high-density lipoprotein (HDL). The optimal CD-MEKC conditions included a separation buffer mixture of 5 mM sodium phosphate, 40 mM bile salts (50% sodium cholate and 50% sodium deoxycholate), 25 mM carboxymethyl-beta-CD (CM-beta-CD) and pH 7.0. The separation voltage was 15 kV, and the capillary temperature was 15 degrees. The CD-MEKC profiles of human HDL apolipoproteins showed good repeatability and sensitivity. Linear analysis has been performed for human apolipoprotein standards including apos AI, AII, CI, CII, CIII and E. Linear regression lines with coefficients of determination (R-2) greater than 0.99 were obtained for apos AI, AII, CI, CII and E. The linear ranges for the six apolipoproteins were within 0.18-0.70 mg/mL, and the concentration limits of detection (LOD) were lower than 0.0617 mg/mL. Apos AI, AII, CI and CIII were identified and quantified in human HDL by comparing with apolipoprotein standards. Furthermore, the CD-MEKC profiles of uremic patients differed significantly from healthy subjects. The concentration ratios of apo AI/apo CIII were significantly lower for uremic patients than healthy subjects. This study demonstrated the feasibility of determining human HDL apolipoproteins by CD-MEKC. In the future, it might help monitor the progression of uremia and cardiovascular disease. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 173
页数:10
相关论文
共 50 条
  • [1] Cyclodextrin-micellar electrokinetic chromatography of apolipoproteins on human very low-density lipoprotein
    Shieh, Ying-Tzu
    Chang, Chiz-Tzung
    Toh, Jia-Jia
    Hsu, Yun-Hsun
    Chang, I-Ting
    Hsia, Min-Hui
    Liu, Mine-Yine
    ELECTROPHORESIS, 2020, 41 (15) : 1333 - 1343
  • [2] Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients
    Wang, Jiajing
    Cao, Yuqing
    Wu, Shengyuan
    Wang, Shuowen
    Zhao, Xin
    Zhou, Tingting
    Lou, Yuefen
    Fan, Guorong
    MOLECULES, 2017, 22 (04):
  • [3] Intrinsic enzymes of high-density lipoprotein
    Le, Ngoc-Anh
    Walter, Mary F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (01) : 20 - 30
  • [4] Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
    Smith, Jonathan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 382 - 388
  • [5] From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease
    Sacks, Frank M.
    Jensen, Majken K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (03) : 487 - 499
  • [6] Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
    Honda, Hirokazu
    Hirano, Tsutomu
    Ueda, Masashi
    Kojima, Shiho
    Mashiba, Shinichi
    Hayase, Yasuyuki
    Michihata, Tetsuo
    Shishido, Kanji
    Takahashi, Keiko
    Hosaka, Nozomu
    Ikeda, Misa
    Sanada, Daisuke
    Shibata, Takanori
    PLOS ONE, 2017, 12 (05):
  • [7] Novel Therapies Focused on the High-Density Lipoprotein Particle
    van Capelleveen, Julian C.
    Brewer, H. Bryan
    Kastelein, John J. P.
    Hovingh, G. Kees
    CIRCULATION RESEARCH, 2014, 114 (01) : 193 - 204
  • [8] miRNAs and High-Density Lipoprotein metabolism
    Baldan, Angel
    Vallim, Thomas Q. de Aguiar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (12): : 2053 - 2061
  • [9] High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis
    Favari, Elda
    Thomas, Michael J.
    Sorci-Thomas, Mary G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 71 (06) : 325 - 331
  • [10] High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein
    Rodriguez-Carrio, Javier
    Alperi-Lopez, Mercedes
    Lopez, Patricia
    Lopez-Mejias, Raquel
    Alonso-Castro, Sara
    Abal, Francisco
    Ballina-Garcia, Francisco J.
    Gonzalez-Gay, Miguel A.
    Suarez, Ana
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (04) : 1043 - 1054